Antidepressant efficacy is inflated by the cumulative impact of publication bias, outcome reporting bias, spin, and citation bias on the evidence base. 🧵1/12

Ton Schumacher is closing #CancerHostTI24 discussing neoantigens and neoadjuvant therapy. With his research group he created technologies to dissect T cell responses in cancer and contributed to the development of adoptive T cell therapies and neoadjuvant cancer immunotherapy.

It's not the models, it's the data! We show that a substantial proportion of a widely used TCR-pMHC database does not functionally validate, causing underestimation of performance of TCR-pMHC prediction models.

Very important work! We've been waiting for someone to do this. It has been clear for some time that a proportion of aggregated TCR-pMHC data might not be reliable. It will be interesting to reassess performance in light of this more robustly validated data.

Incredibly excited and grateful for the opportunity to present at Antwerp TCR in 3 weeks. There’s no place more relevant to showcase what we have been up to. If you want to have a sneak preview; check out the thread of MariusMessemaker & our pre-print biorxiv.org/content/10.110…